Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer
Author:
Publisher
Wiley
Subject
Otorhinolaryngology
Reference15 articles.
1. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation
2. Concomitant Chemotherapy and Reirradiation as Management for Recurrent Cancer of the Head and Neck
3. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease
4. Pilot Study for the Evaluation of Simultaneous Cisplatin/5-Fluorouracil Infusion and Limited Radiation Therapy in Regionally Recurrent Head and Neck Cancer (EST P-C385)
5. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria;International Journal of Radiation Oncology*Biology*Physics;2022-07
2. Validation of Monte Carlo 131 I radiopharmaceutical dosimetry workflow using a 3D‐printed anthropomorphic head and neck phantom;Medical Physics;2022-06-06
3. Oral Cancer Management;Peterson’s Principles of Oral and Maxillofacial Surgery;2022
4. The Evolving Role of Radiotherapy for Head and Neck Cancer;Hematology/Oncology Clinics of North America;2020-02
5. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast;JAMA Oncology;2020-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3